Is double inactivation of the Nf1 gene responsible for the development of congenital pseudarthrosis of the tibia associated with NF1?

被引:23
作者
Lee, Sang Min [1 ]
Choi, In Ho [2 ]
Lee, Dong Yeon [2 ]
Lee, Hye Ran [2 ]
Park, Moon Seok [2 ]
Yoo, Won Joon [2 ]
Chung, Chin Youb [2 ]
Cho, Tae-Joon [2 ]
机构
[1] Eulji Univ, Coll Med, Dept Orthopaed Surg, Taejon 302799, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Orthopaed Surg, Seoul 110744, South Korea
关键词
congenital pseudarthrosis of the tibia; neurofibromatosis type 1; fibrous hamartoma; loss of heterozygosity; clonality; X-CHROMOSOME INACTIVATION; NEUROFIBROMATOSIS TYPE-1; POLYMORPHISM; METHYLATION; HAMARTOMA; REPEAT; BENIGN; RATIOS; TUMORS; MOUSE;
D O I
10.1002/jor.22121
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The pathogenic mechanism responsible for congenital pseudarthrosis of the tibia (CPT) is not well understood although the possibility of double inactivation of the neurofibromatosis type 1 (Nf1) gene has been suggested. In the present study, loss of heterozygosity was investigated in fibrous hamartoma tissues harvested from 16 patients with CPT associated with NF1 using four genetic markers that span the Nf1 gene. Based on the assumption that a single cell with double inactivation of Nf1 would undergo clonal growth and cause fibrous hamartoma, we investigated clonality in fibrous hamartoma tissues by analyzing X-chromosome inactivation patterns in 11 female patients. Loss of Nf1 heterozygosity in fibrous hamartoma tissues was observed at one or two genetic markers in 4 out of the 16 patients tested. In clonality assays, 3 of 11 patients showed a clonal growth pattern, 5 a non-clonal pattern, and 3 were non-informative. These findings support that double inactivation of the Nf1 gene and subsequent clonal growth could be a pathogenic feature of the fibrous hamartoma tissue at least in some of the CPT but might not be essential requirements of CPT development. (c) 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 30:15351540, 2012
引用
收藏
页码:1535 / 1540
页数:6
相关论文
共 31 条
  • [1] ALLEN RC, 1992, AM J HUM GENET, V51, P1229
  • [2] Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)?
    Alwan, S
    Tredwel, SJ
    Friedman, JM
    [J]. CLINICAL GENETICS, 2005, 67 (05) : 378 - 390
  • [3] Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells
    Bollag, G
    Clapp, DW
    Shih, S
    Adler, F
    Zhang, YY
    Thompson, P
    Lange, BJ
    Freedman, MH
    McCormick, F
    Jacks, T
    Shannon, K
    [J]. NATURE GENETICS, 1996, 12 (02) : 144 - 148
  • [4] The human androgen receptor X-chromosome inactivation assay for clonality diagnostics of natural killer cell proliferations
    Boudewijns, Michael
    van Dongen, Jacques J. M.
    Langerak, Anton W.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (03) : 337 - 344
  • [5] Busque L, 1996, BLOOD, V88, P59
  • [6] Biologic Characteristics of Fibrous Hamartoma from Congenital Pseudarthrosis of the Tibia Associated with Neurofibromatosis Type 1
    Cho, Tae-Joon
    Seo, Joong-Bae
    Lee, Hye Ran
    Yoo, Won Joon
    Chung, Chin Youb
    Choi, In Ho
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2008, 90A (12) : 2735 - 2744
  • [7] NF1 tumor suppressor gene function: Narrowing the GAP
    Cichowski, K
    Jacks, T
    [J]. CELL, 2001, 104 (04) : 593 - 604
  • [8] Mouse models of tumor development in neurofibromatosis type 1
    Cichowski, K
    Shih, TS
    Schmitt, E
    Santiago, S
    Reilly, K
    McLaughlin, ME
    Bronson, RT
    Jacks, T
    [J]. SCIENCE, 1999, 286 (5447) : 2172 - 2176
  • [9] Correa CL, 1999, HUM MUTAT, V14, P387, DOI 10.1002/(SICI)1098-1004(199911)14:5<387::AID-HUMU4>3.0.CO
  • [10] 2-4